Showing results (161-170 of 195) with videos related to
Sort By:
Pageof 20
Journal of Diabetes and Its Complications|August 6, 2013
Differences in inpatient glycemic control and response to subcutaneous insulin therapy between medicine and surgery patients with type 2 diabetesDawn Smiley, Guillermo E Umpierrez, Kathie Hermayer, et al.JAMA Network Open|April 18, 2022
Potential Gains in Life Expectancy Associated With Achieving Treatment Goals in US Adults With Type 2 DiabetesHamed Kianmehr, Ping Zhang, Jing Luo, et al.Journal of Diabetes and Its Complications|March 5, 2005
The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trialGeorge L Bakris, David S H Bell, Vivian Fonseca, et al.Diabetes Care|March 11, 2010
Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trialRodica Pop-Busui, Gregory W Evans, Hertzel C Gerstein, et al.Journal of Diabetes|August 18, 2016
Adherence, persistence, and treatment discontinuation with sitagliptin compared with sulfonylureas as add-ons to metformin: A retrospective cohort database studyZachary T Bloomgarden, Kaan Tunceli, Jinan Liu, et al.Diabetes Care|February 16, 2013
Determinants of weight gain in the action to control cardiovascular risk in diabetes trialVivian Fonseca, Roberta McDuffie, Jorge Calles, et al.Diabetes, Obesity & Metabolism|October 4, 2022
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist usePeter Rossing, Rajiv Agarwal, Stefan D Anker, et al.Hypertension (Dallas, Tex. : 1979)|November 16, 2005
Differential effects of beta-blockers on albuminuria in patients with type 2 diabetesGeorge L Bakris, Vivian Fonseca, Richard E Katholi, et al.JAMA|November 13, 2004
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trialGeorge L Bakris, Vivian Fonseca, Richard E Katholi, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|November 6, 2007
Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI TrialJackson T Wright, George L Bakris, David S H Bell, et al.Pageof 20